Verano Holdings (VRNO) Total Debt (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Total Debt of $395.1 million for Q1 2026, down 2.31% year-over-year from $404.4 million in Q1 2025, and up 0.75% quarter-over-quarter from $392.2 million in Q4 2025.
Verano Holdings (VRNO) Total Debt (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Total Debt for 6 consecutive years, with $395.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt fell 2.31% year-over-year to $395.1 million; the TTM figure through Mar 2026 stood at $395.1 million (down 2.31% YoY), while the FY2025 annual figure was $392.2 million, down 9.22% from the prior year.
- Total Debt improved to $395.1 million in Q1 2026 per VRNO's latest filing, from $392.2 million in the prior quarter.
- Across five years, Total Debt topped out at $445.9 million in Q3 2022 and bottomed at -$4.8 million in Q1 2022.
- Historically, Total Debt has averaged $392.0 million across 5 years, with a median of $404.4 million in 2025.
- Annual changes were most pronounced in 2022 — Total Debt dropped 17.11% — and 2023, when it jumped 9136.24%.
- Verano Holdings' Total Debt stood at $413.0 million in 2022, then dropped by 3.74% to $397.6 million in 2023, then climbed by 8.67% to $432.0 million in 2024, then dropped by 9.22% to $392.2 million in 2025, then increased by 0.75% to $395.1 million in 2026.
- Business Quant data shows VRNO's Total Debt at $395.1 million in Q1 2026, $392.2 million in Q4 2025, and $400.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 760.00 Mn |
| 10 | Verano Holdings | 438.82 Mn | 353.62 Mn | 99.70 Mn | 403.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 403.16 Mn |
| Mar 31, 2026 | 395.10 Mn |
| Dec 31, 2025 | 392.15 Mn |
| Sep 30, 2025 | 400.76 Mn |
| Jun 30, 2025 | 403.76 Mn |
| Mar 31, 2025 | 404.44 Mn |
| Dec 31, 2024 | 432.00 Mn |
| Sep 30, 2024 | 442.68 Mn |
| Jun 30, 2024 | 399.83 Mn |
| Mar 31, 2024 | 444.69 Mn |
| Dec 31, 2023 | 397.55 Mn |
| Sep 30, 2023 | 422.18 Mn |
| Jun 30, 2023 | 441.80 Mn |
| Mar 31, 2023 | 430.13 Mn |
| Dec 31, 2022 | 413.00 Mn |
| Sep 30, 2022 | 445.87 Mn |
| Jun 30, 2022 | 402.63 Mn |
| Mar 31, 2022 | -4.76 Mn |
| Dec 31, 2021 | 498.27 Mn |